Hepatic Surgery in Patients with Cirrhosis: Mitigating Risk

Feasibility, Concerns, and Outcomes


Patients with cirrhosis are at particularly high risk for hepatic malignancies and other operative conditions; however, they are at commensurately high risk for perioperative morbidity and mortality. Understanding these patients’ anatomical and physiological differences and their inherent limitations is the key to establishing a safe plan of care for them. In properly selected patients, hepatic resection even in the setting of cirrhosis can yield favorable postoperative and oncological outcomes. This chapter will discuss indications for surgical intervention, risk stratification and modification, alterations in surgical technique that can be helpful in cirrhotic patients as well as alternatives to operative therapy that should be employed in certain instances, and finally will discuss postoperative care and outcomes.


Hepatectomy Outcome Portal hypertension Surgery 


  1. 1.
    Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371(9615):838–51.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Roayaie S, Obeidat K, Sposito C, et al. Resection of hepatocellular cancer </=2 cm: results from two Western centers. Hepatology. 2013;57(4):1426–35.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010;30(1):61–74.CrossRefPubMedGoogle Scholar
  4. 4.
    Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329–38.CrossRefPubMedGoogle Scholar
  5. 5.
    Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001;33(6):1394–403.CrossRefPubMedGoogle Scholar
  7. 7.
    Iwatsuki S, Starzl TE, Sheahan DG, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg. 1991;214(3):221–8; discussion 228–9.Google Scholar
  8. 8.
    Cai B, Liao K, Song XQ, Wei WY, Zhuang Y, Zhang S. Patients with chronically diseased livers have lower incidence of colorectal liver metastases: a meta-analysis. PLoS One. 2014;9(9):e108618.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Sorensen HT, Mellemkjaer L, Jepsen P, et al. Risk of cancer in patients hospitalized with fatty liver: a Danish cohort study. J Clin Gastroenterol. 2003;36(4):356–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Sorensen HT, Friis S, Olsen JH, et al. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology. 1998;28(4):921–5.CrossRefPubMedGoogle Scholar
  11. 11.
    Dahl E, Rumessen J, Gluud LL. Systematic review with meta-analyses of studies on the association between cirrhosis and liver metastases. Hepatol Res Off J Jpn Soc Hepatol. 2011;41(7):618–25.CrossRefGoogle Scholar
  12. 12.
    Rosen CB, Heimbach JK, Gores GJ. Surgery for cholangiocarcinoma: the role of liver transplantation. HPB (Oxford). 2008;10(3):186–9.CrossRefGoogle Scholar
  13. 13.
    Cho YK, Kim JK, Kim WT, Chung JW. Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis. Hepatology. 2010;51(4):1284–90.CrossRefPubMedGoogle Scholar
  14. 14.
    Livraghi T, Meloni F, Di Stasi M, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology. 2008;47(1):82–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Ikai I, Arii S, Kojiro M, et al. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer. 2004;101(4):796–802.CrossRefPubMedGoogle Scholar
  16. 16.
    Lee JI, Lee JW, Kim YS, Choi YA, Jeon YS, Cho SG. Analysis of survival in very early hepatocellular carcinoma after resection. J Clin Gastroenterol. 2011;45(4):366–71.CrossRefPubMedGoogle Scholar
  17. 17.
    European Association For The Study Of The L, European Organisation For R, Treatment Of C. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56(4):908–943.Google Scholar
  18. 18.
    Fuks D, Dokmak S, Paradis V, Diouf M, Durand F, Belghiti J. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology. 2012;55(1):132–40.CrossRefPubMedGoogle Scholar
  19. 19.
    Malik HZ, Hamady ZZ, Adair R, et al. Prognostic influence of multiple hepatic metastases from colorectal cancer. Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2007;33(4):468–73.CrossRefGoogle Scholar
  20. 20.
    Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239(6):818–25 ; discussion 825–7.Google Scholar
  21. 21.
    Ko S, Jo H, Yun S, Park E, Kim S, Seo HI. Comparative analysis of radiofrequency ablation and resection for resectable colorectal liver metastases. World J Gastroenterol. 2014;20(2):525–31.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Park IJ, Kim HC, Yu CS, Kim PN, Won HJ, Kim JC. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Ann Surg Oncol. 2008;15(1):227–32.CrossRefPubMedGoogle Scholar
  23. 23.
    Vauthey JN, Chaoui A, Do KA, et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery. 2000;127(5):512–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Dahiya D, Wu TJ, Lee CF, Chan KM, Lee WC, Chen MF. Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience. Surgery. 2010;147(5):676–85.CrossRefPubMedGoogle Scholar
  25. 25.
    Tang YH, Wen TF, Chen X. Anatomic versus non-anatomic liver resection for hepatocellular carcinoma: a systematic review. Hepato-Gastroenterology. 2013;60(128):2019–25.PubMedGoogle Scholar
  26. 26.
    Schroeder RA. Predictive indices of morbidity and mortality after liver resection. Ann Surg. 2006;244(4):637.CrossRefPubMedCentralGoogle Scholar
  27. 27.
    Teh SH, Christein J, Donohue J, et al. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: model of end-stage liver disease (MELD) score predicts perioperative mortality. J Gastrointest Surg 2005;9(9):1207–15; discussion 1215.Google Scholar
  28. 28.
    Cucchetti A, Ercolani G, Vivarelli M, et al. Is portal hypertension a contraindication to hepatic resection? Ann Surg. 2009;250(6):922–8.CrossRefPubMedGoogle Scholar
  29. 29.
    Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T. Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis. Ann Surg. 1987;206(1):30–9.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149(5):713–24.CrossRefPubMedGoogle Scholar
  31. 31.
    Lautz HU, Selberg O, Korber J, Burger M, Muller MJ. Protein-calorie malnutrition in liver cirrhosis. Clin Investig. 1992;70(6):478–86.CrossRefPubMedGoogle Scholar
  32. 32.
    Dabbagh O, Oza A, Prakash S, Sunna R, Saettele TM. Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease. Chest. 2010;137(5):1145–9.CrossRefPubMedGoogle Scholar
  33. 33.
    Buell JF, Cherqui D, Geller DA, et al. The international position on laparoscopic liver surgery: the Louisville Statement, 2008. Ann Surg. 2009;250(5):825–30.CrossRefPubMedGoogle Scholar
  34. 34.
    Truant S, Bouras AF, Hebbar M, et al. Laparoscopic resection vs. open liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: a case-matched study. Surg Endosc. 2011;25(11):3668–77.CrossRefPubMedGoogle Scholar
  35. 35.
    Jones RL, Qian YM, Chan KM, Yim AP. Characterization of a prostanoid EP3-receptor in guinea-pig aorta: partial agonist action of the non-prostanoid ONO-AP-324. Br J Pharmacol. 1998;125(6):1288–96.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Yang Y, Zhao LH, Fu SY, et al. Selective hepatic vascular exclusion versus pringle maneuver in partial hepatectomy for liver hemangioma compressing or involving the major hepatic veins. Am Surg. 2014;80(3):236–40.PubMedGoogle Scholar
  37. 37.
    Chouillard EK, Gumbs AA, Cherqui D. Vascular clamping in liver surgery: physiology, indications and techniques. Ann Surg Innov Res. 2010;4:2.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368(1):11–21.CrossRefPubMedGoogle Scholar
  39. 39.
    Soubrane O, Schwarz L, Cauchy F, et al. A conceptual technique for laparoscopic right hepatectomy based on facts and oncologic principles: the caudal approach. Ann Surg. 2015;261(6):1226–31.CrossRefPubMedGoogle Scholar
  40. 40.
    Leung U, Fong Y. Robotic liver surgery. Hepatobil Surg Nutr. 2014;3(5):288–94.Google Scholar
  41. 41.
    Cherqui D, Laurent A, Tayar C, et al. Laparoscopic liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: midterm results and perspectives. Ann Surg. 2006;243(4):499–506.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Worhunsky DJ, Dua MM, Tran TB, et al. Laparoscopic hepatectomy in cirrhotics: safe if you adjust technique. Surg Endosc. 2016;30:4307–14.CrossRefPubMedGoogle Scholar
  43. 43.
    Capussotti L, Nuzzo G, Polastri R, Giuliante F, Muratore A, Giovannini I. Continuous versus intermittent portal triad clamping during hepatectomy in cirrhosis. Results of a prospective, randomized clinical trial. Hepato-Gastroenterology. 2003;50(52):1073–7.PubMedGoogle Scholar
  44. 44.
    Fong Y, Brennan MF, Brown K, Heffeman N, Blumgart LH. Drainage is unnecessary after elective liver resection. Am J Surg. 1996;171(1):158–62.CrossRefPubMedGoogle Scholar
  45. 45.
    Liu CL, Fan ST, Lo CM, et al. Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases. Ann Surg. 2004;239(2):194–201.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Fuster J, Llovet JM, Garcia-Valdecasas JC, et al. Abdominal drainage after liver resection for hepatocellular carcinoma in cirrhotic patients: a randomized controlled study. Hepato-Gastroenterology. 2004;51(56):536–40.PubMedGoogle Scholar
  47. 47.
    Balzan S, Belghiti J, Farges O, et al. The “50-50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242(6):824–9.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Paugam-Burtz C, Janny S, Delefosse D, et al. Prospective validation of the “fifty-fifty” criteria as an early and accurate predictor of death after liver resection in intensive care unit patients. Ann Surg. 2009;249(1):124–8.CrossRefPubMedGoogle Scholar
  49. 49.
    Hackl C, Schlitt HJ, Renner P, Lang SA. Liver surgery in cirrhosis and portal hypertension. World J Gastroenterol. 2016;22(9):2725.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    de Goede B, Klitsie PJ, Hagen SM, et al. Meta-analysis of laparoscopic versus open cholecystectomy for patients with liver cirrhosis and symptomatic cholecystolithiasis. Br J Surg. 2013;100(2):209–16.CrossRefPubMedGoogle Scholar
  51. 51.
    Pessaux P, Msika S, Atalla D, Hay JM, Flamant Y, French Association for Surgical R. Risk factors for postoperative infectious complications in noncolorectal abdominal surgery: a multivariate analysis based on a prospective multicenter study of 4718 patients. Arch Surg. 2003;138(3):314–24.CrossRefPubMedGoogle Scholar
  52. 52.
    Schindl MJ, Redhead DN, Fearon KC, et al. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut. 2005;54(2):289–96.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of SurgeryCity of Hope National Medical CenterDuarteUSA

Personalised recommendations